Press Releases

WASHINGTON — The Select Subcommittee on the Coronavirus Pandemic held a hearing titled “Examining the White House’s Role in Pandemic Preparedness and Response” to discuss the Office of Pandemic Preparedness and Response Policy’s (OPPR) role in responding to and preventing future pandemics. The newly appointed Director of OPPR, Major General Paul Fredrichs, explained that the office’s main purpose is to convene pandemic preparedness and response groups from across the federal ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) will speak at an event hosted by The Hill on Wednesday, March 6 to discuss bipartisan efforts aimed at reforming Pharmacy Benefit Managers (PBMs). The House Committee on Oversight and Accountability had held multiple hearings during the 118th Congress to examine how Pharmacy Benefit Managers (PBMs) have monopolized the pharmaceutical marketplace and pushed ...

WASHINGTON — Today, Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) announced a subpoena to compel former New York Governor Andrew Cuomo to appear for a deposition on May 24, 2024. On March 25, 2020, Governor Cuomo issued a mandate that forced New York nursing homes and long-term care facilities to admit or re-admit potentially contagious and untested COVID-19 patients. This order recklessly exposed New York’s most vulnerable population to ...

WASHINGTON—Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs Chairman Pat Fallon (R-Texas.) today announced a hearing titled “The Power Struggle: Examining the Reliability and Security of America’s Electrical Grid” to examine the risks associated with Biden Administration actions to rapidly expand electric power demand across ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is today investigating the United States Trade Representative’s (USTR) secretive communications with ideologically aligned groups and lack of commitment to a comprehensive consultation process for decisions to abandon longstanding, bipartisan positions on digital trade. The lack of transparency has led USTR to make decisions which put the best interest of U.S. competitiveness, innovation, jobs, and ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and House Committee on the Judiciary Chairman Jim Jordan (R-Ohio) today released the transcript from the committees’ transcribed interview with Jason Galanis. The full transcript can be found here.

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs Chairman Pat Fallon (R-Texas.) are today conducting oversight of the U.S. Equal Employment Opportunity Commission’s (EEOC) enforcement of longstanding prohibitions on racially discriminatory policies in employment practices. In a letter to EEOC Chair Charlotte Burrows, the lawmakers request documents, communications, and a ...

WASHINGTON—The Subcommittee on Cybersecurity, Information Technology, and Government Innovation held a hearing titled, “Made in China: Is GSA Complying with Purchasing Restrictions?” Members discussed with the General Services Administration’s (GSA) Office of Inspector General (OIG) and the GSA Chief Information Officer (CIO) the badly flawed process and research that led ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and House Committee on the Judiciary Chairman Jim Jordan (R-Ohio) today released the transcript from the committees’ transcribed interview with James Biden. The full transcript can be found here.

WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) is investigating possible undue interference on the accelerated approval of Pfizer’s COVID-19 vaccine by the U.S. Food and Drug Administration (FDA). During the Select Subcommittee’s hearing titled “Assessing America’s Vaccine Safety Systems, Part 1,” FDA Director Dr. Peter Marks testified that the FDA’s approval of the COVID-19 ...